In 1999, Time Magazine named Sir Alexander Fleming in its list of the most important people of the 20th Century. The Nobel Prize-winning Scottish physician, microbiologist and pharmacologist’s best known discovery was the world’s first antibiotic substance, Penicillin in 1928. However, Sir Alexander is far from alone when it comes to Scottish legends of pioneering invention and medical innovation. From the top selling skeletal muscle...
Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’. The programme provides simultaneous grant funding and venture capital investment for early stage projects led...
“The Life Sciences Scotland Industry Leadership Group, welcomes the intent of the UK Governments Technical paper dated 6th Aug. It is hugely important that patient safety, continuity of supply of medicines and an understanding of how business can operate in the coming years is communicated such that planning can continue. The Industry Leadership Group maintains its previously communicated position that for the Scottish Life Sciences...
Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, and Elasmogen, an SME focused on the development of next generation biologics, announced today that they have been awarded a grant from Innovate UK through its Innovation in Health and Life Sciences funding programme. The £2M peer reviewed collaborative project entitled ‘A Technology Platform for Next Generation VNAR based...
CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed a £3.15 million equity funding round from existing investors Archangel Investors, Julz and the Scottish Investment Bank. The proceeds will be used to support the completion of the FDA’s Pre-Market Approval (PMA) review process for the CALCIVIS® Imaging System in the United States (US),...
Because you’ll be in with a chance of receiving £100K… Up to £50k in convertible loans Access to their network of experts Lab and office space for up to 12 months Continuous support from the Venture Development team Fear of failure is a feeling many entrepreneurs experience and for some it can even be a barrier to the success of their start-ups. The BioCity Business...